Search

Your search keyword '"A. Ferrarini"' showing total 167 results

Search Constraints

Start Over You searched for: Author "A. Ferrarini" Remove constraint Author: "A. Ferrarini" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
167 results on '"A. Ferrarini"'

Search Results

1. Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study

2. MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

3. Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease

7. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy

9. International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

13. A non-invasive approach to monitor chronic lymphocytic leukemia engraftment in a xenograft mouse model using ultra-small superparamagnetic iron oxide-magnetic resonance imaging (USPIO-MRI)

14. HIF-1α regulates the interaction of chronic lymphocytic leukemia cells with the tumor microenvironment

20. How Age, Comorbidities and Concomitant Medications Influence Ibrutinib Management and Survival in Waldenstrom Macroglobulinemia

22. Slug/β-Catenin–Dependent Proinflammatory Phenotype in Hypoxic Breast Cancer Stem Cells

33. Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience

34. Real-Life Multicentre Study on 547 Patients Affected By Waldenstrom Macroglobulinemia Treated with Chemo-Immunotherapy: Which Is the Best and Most Used First-Line Treatment?

35. Real-World Venetoclax-Obinutuzumab in 232 Treatment Naive CLL Patients: Feasibility and Tolerability

36. Rituximab, Bendamustine and Cytarabine Followed By Venetoclax (V-RBAC) in High-Risk Older Patients with Mantle Cell Lymphoma: A Phase 2 Study By the Fondazione Italiana Linfomi (FIL)

45. Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy

47. Continuous Venetoclax in Previously Untreated Patients with Chronic Lymphocytic Leukemia and TP53 Abnormalities. a Study of the Italian Campus CLL

Catalog

Books, media, physical & digital resources